TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Pharmex AS
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
16,439
|
16,017
|
12,788 |
Financial expenses |
507
|
584
|
72 |
Earnings before taxes |
2,396
|
2,358
|
1,741 |
Total assets |
7,244
|
6,516
|
6,792 |
Current assets |
7,244
|
6,516
|
6,792 |
Current liabilities |
2,527
|
2,023
|
2,797 |
Equity capital |
4,573
|
4,294
|
3,709 |
- share capital |
398
|
425
|
448 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
63.1%
|
65.9%
|
54.6% |
Turnover per employee | |||
Profit as a percentage of turnover |
14.6%
|
14.7%
|
13.6% |
Return on assets (ROA) |
40.1%
|
45.2%
|
26.7% |
Current ratio |
286.7%
|
322.1%
|
242.8% |
Return on equity (ROE) |
52.4%
|
54.9%
|
46.9% |
Change turnover |
1,406
|
3,901
|
2,765 |
Change turnover % |
9%
|
32%
|
28% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.